|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 218.62 USD | +1.09% |
|
+0.00% | -1.95% |
| 01-13 | Veeva Systems Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 01:30 PM | |
| 01-08 | Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership | MT |
Company Valuation: Veeva Systems Inc.
Data adjusted to current consolidation scope
| Fiscal Period: January | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 41,871 | 36,371 | 26,553 | 33,396 | 37,870 | 35,549 | - | - |
| Change | - | -13.13% | -27% | 25.77% | 13.4% | -6.13% | - | - |
| Enterprise Value (EV) 1 | 40,208 | 33,995 | 23,450 | 29,368 | 32,720 | 28,902 | 27,232 | 26,101 |
| Change | - | -15.45% | -31.02% | 25.24% | 11.41% | -11.67% | -5.78% | -4.15% |
| P/E ratio | 117x | 89.9x | 56.9x | 64.4x | 54x | 40.8x | 36.5x | 31.7x |
| PBR | 18.4x | 12.5x | 7.45x | 7.3x | 6.61x | 4.82x | 4.08x | 3.52x |
| PEG | - | 7.9x | 4x | 8.78x | 1.6x | 1.8x | 3.1x | 2.1x |
| Capitalization / Revenue | 28.6x | 19.7x | 12.3x | 14.1x | 13.8x | 11.2x | 10x | 8.87x |
| EV / Revenue | 27.4x | 18.4x | 10.9x | 12.4x | 11.9x | 9.11x | 7.66x | 6.51x |
| EV / EBITDA | 65.7x | 43.2x | 27.3x | 33.6x | 27.9x | 20.1x | 16.8x | 13.6x |
| EV / EBIT | 69x | 44.8x | 28.2x | 34.9x | 28.4x | 20.4x | 17.2x | 14.1x |
| EV / FCF | 74.1x | 45.3x | 30.6x | 33.2x | 30.6x | 21.7x | 17.7x | 15.3x |
| FCF Yield | 1.35% | 2.21% | 3.27% | 3.01% | 3.27% | 4.6% | 5.64% | 6.55% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.36 | 2.63 | 3 | 3.22 | 4.32 | 5.296 | 5.922 | 6.823 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,465 | 1,851 | 2,155 | 2,364 | 2,747 | 3,172 | 3,556 | 4,007 |
| EBITDA 1 | 612.3 | 786.1 | 859.6 | 875.2 | 1,173 | 1,437 | 1,620 | 1,922 |
| EBIT 1 | 582.8 | 758.7 | 830.5 | 842.5 | 1,152 | 1,419 | 1,581 | 1,847 |
| Net income 1 | 380 | 427.4 | 487.7 | 525.7 | 714.1 | 894.9 | 1,019 | 1,194 |
| Net Debt 1 | -1,664 | -2,376 | -3,103 | -4,028 | -5,150 | -6,647 | -8,317 | -9,448 |
| Reference price 2 | 276.44 | 236.54 | 170.55 | 207.41 | 233.26 | 216.26 | 216.26 | 216.26 |
| Nbr of stocks (in thousands) | 151,466 | 153,764 | 155,688 | 161,016 | 162,350 | 164,382 | - | - |
| Announcement Date | 3/2/21 | 3/2/22 | 3/1/23 | 2/29/24 | 3/5/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 40.83x | 9.11x | 20.12x | -.--% | 35.55B | |
| 122.85x | 67.46x | 85.3x | 0.4% | 13.14B | |
| 80.64x | 12.22x | 54.5x | 0.92% | 4.81B | |
| -12.9x | 20.61x | -76.2x | - | 2.91B | |
| 166.31x | - | - | -.--% | 2.2B | |
| -117.15x | - | - | - | 1.45B | |
| 569x | - | - | 0.53% | 1.26B | |
| Average | 121.37x | 27.35x | 20.93x | 0.37% | 8.76B | |
| Weighted average by Cap. | 70.61x | 23.56x | 33.27x | 0.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- VEEV Stock
- Valuation Veeva Systems Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition